共 50 条
Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
被引:26
|作者:
Yang, Shuanghui
[1
,2
]
Li, Huan
[2
,3
]
Xu, Ling
[2
,4
]
Deng, Zhenhan
[5
]
Han, Wei
[2
]
Liu, Yanting
[2
]
Jiang, Wenqi
[2
]
Zu, Youli
[2
]
机构:
[1] Cent South Univ, Xiangya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China
[2] Houston Methodist Hosp, Dept Pathol & Genom Med, 6565 Fannin St, Houston, TX 77030 USA
[3] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha 410008, Hunan, Peoples R China
[4] Jinan Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510632, Guangdong, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Dept Orthopaed, Changsha 410008, Hunan, Peoples R China
来源:
MOLECULAR THERAPY-NUCLEIC ACIDS
|
2018年
/
13卷
关键词:
B-CELL LYMPHOMA;
ANTIBODY-TARGETED CHEMOTHERAPY;
CHRONIC LYMPHOCYTIC-LEUKEMIA;
FLOW-CYTOMETRIC ANALYSIS;
CANCER-CELLS;
BETA-ARRESTINS;
DNA APTAMER;
MONOCLONAL-ANTIBODY;
CD30;
EXPRESSION;
DRUG CONJUGATE;
D O I:
10.1016/j.omtn.2018.08.023
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Precision medicine has recently emerged as a promising strategy for cancer therapy because it not only specifically targets cancer cells but it also does not have adverse effects on normal cells. Oligonucleotide aptamers are a class of small molecule ligands that can specifically bind to their targets on cell surfaces with high affinity. Aptamers have great potential in precision cancer therapy due to their unique physical, chemical, and biological properties. Therefore, aptamer technology has been widely investigated for biomedical and clinical applications. This review focuses on the potential applications of aptamer technology as a new tool for precision treatment of hematological malignancies, including leukemia, lymphoma, and multiple myeloma.
引用
收藏
页码:164 / 175
页数:12
相关论文